Shorts

0:46
Survival With Bispecific Combo Favors Early Use in Myeloma
6 months ago
by
Roberto Mina, MD

0:33
The Key Test to Confirm RMC Diagnosis is Immunohistochemistry for INI1
6 months ago
by
Pavlos Msaouel, MD, PhD

0:48
The Need for HRR Mutation Testing in Prostate Cancer
6 months ago
by
Sandy Srinivas, MD

1:27
Are We Nearing the End of 7+3 Alone in AML?
6 months ago
by
Richard Stone, MD

0:32
One Analogy Doesn't Work for Every Patient
6 months ago
by
Sanjay K. Juneja, MD(+1 more)

0:34
Managing Toxicities in Patients on Erdafitinib Therapy
6 months ago
by
Thomas W. Flaig, MD

0:59
The Power of a Gut Feeling in Cancer Care
6 months ago
by
Sanjay K. Juneja, MD

0:38
New Frontiers in Urothelial Carcinoma
6 months ago
by
Thomas W. Flaig, MD

0:32
CLL17 3-Year Update: Who May Benefit From Continuous Therapy?
6 months ago
by
Nicole Lamanna, MD

1:00
Bringing Clinical Trials Into the Community
6 months ago
by
Danny Nguyen, MD

0:43
Early-Onset CRC: Thinking Beyond the Tumor
6 months ago
by
Patrick Boland, MD

0:46
How AI is Revolutionizing Clinical Trials
6 months ago
by
Danny Nguyen, MD

0:57
Why Clinical Trials Aren't Just a Last Resort for Cancer
6 months ago
by
Danny Nguyen, MD

0:55
Big Shifts Ahead in Lung Cancer: New KRAS Data and Paradigm Changes
6 months ago
by
Christine Bestvina, MD

0:28
Decentralized Clinical Trials: Reducing the Logistical Burden of Participation
6 months ago
by
Inna Gong, MD, PhD

1:18
Why Women Face Longer Delays in Lung Cancer Diagnosis
6 months ago
by
Narjust Florez, MD

0:57
A “Cancer Genome Atlas” for Immune Profiles?
6 months ago
by
Won Jin Ho, MD

0:32
Confronting Feelings of Guilt in Younger Patients
6 months ago
by
Narjust Florez, MD

0:51
Why Young Women's Lung Cancer Symptoms Are Often Ignored
6 months ago
by
Narjust Florez, MD

1:07
Why ZIP Code Shouldn't Determine Cancer Outcomes
6 months ago
by
Pallav K. Mehta, MD(+1 more)

0:52
Guideline Updates in Lymphoma Treatment
6 months ago
by
Hua-Jay "Jeff" Cherng, MD

0:31
Why You Shouldn't Wait to Treat MDS
6 months ago
by
David Sallman, MD

0:32
My Strategy for MDS Patients Waiting Transplant
6 months ago
by
David Sallman, MD

0:50
Why Haven't Trial Participation Rates Improved?
6 months ago
by
Inna Gong, MD, PhD

0:55
Combating Misinformation: The Truth About the HPV Vaccine
6 months ago
by
Natalie Berger, MD

0:30
Are We Being Too Strict With Clinical Trial Eligibility?
6 months ago
by
Christine Bestvina, MD

0:33
Why Lung Cancer is Now "12 Different Diseases"
6 months ago
by
Christine Bestvina, MD

1:04
MajesTEC-3 Outcomes Lead to Rapid Myeloma Combo Approval
6 months ago
by
Luciano Costa, MD, PhD

0:47
The Problem With MRD Testing in Breast Cancer
6 months ago
by
Paolo Tarantino, MD

1:30
How Mezigdomide Reinvigorates the Immune System
6 months ago
by
Paul G. Richardson, MD
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Fast Track Designation to TRE-515 for KRAS G12C NSCLC
2
Pirtobrutinib Gains FDA Approval for Frontline CLL/SLL in Select Patients
3
NDA Submission Initiated for Zipalertinib Combo in EGFR Exon 20+ NSCLC
4
Ubamatamab Shows Durable Responses in Low-Grade Serous Ovarian Cancer
5
